Histological and Endoscopic evaluation of Remission induced by Infliximab in moderately to severely active ulcerative Colitis Patients.
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2013
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms HERICA
- 10 Jun 2017 Biomarkers information updated
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2012 Actual patient number (21) added as reported by ClinicalTrials.gov.